IBD: Could oral Janus kinase inhibitor be a new drug treatment for active ulcerative colitis?
- PMID: 22945442
- DOI: 10.1038/nrgastro.2012.170
IBD: Could oral Janus kinase inhibitor be a new drug treatment for active ulcerative colitis?
Comment on
-
Tofacitinib, an oral Janus kinase inhibitor, in active ulcerative colitis.N Engl J Med. 2012 Aug 16;367(7):616-24. doi: 10.1056/NEJMoa1112168. N Engl J Med. 2012. PMID: 22894574 Clinical Trial.
References
-
- N Engl J Med. 2012 Aug 16;367(7):616-24 - PubMed
Publication types
LinkOut - more resources
Full Text Sources
